These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 766188)

  • 1. Acute leukemia in polycythemia vera.
    Landaw SA
    Semin Hematol; 1976 Jan; 13(1):33-48. PubMed ID: 766188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
    Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
    Ellis JT; Peterson P; Geller SA; Rappaport H
    Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P.
    Krańik W
    Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
    Parmentier C; Gardet P
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of polycythaemia vera and essential thrombocythaemia.
    Tefferi A; Silverstein MN
    Baillieres Clin Haematol; 1998 Dec; 11(4):769-85. PubMed ID: 10640216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of polycythemia vera: use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. The French Polycythemia Study Group.
    Najean Y; Rain JD
    Blood; 1997 Apr; 89(7):2319-27. PubMed ID: 9116275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute leukemia in polycythemia vera.
    Landaw SA
    Semin Hematol; 1986 Apr; 23(2):156-65. PubMed ID: 3704667
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
    Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR
    N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of polycythemia. I--Using radiophosphorus with or without treatment in 483 patients over 65 years of age].
    Najean Y; Rain JD; Goguel A; Grange MJ; Vigneron N; Dupuy E; Mougeot-Martin M
    Ann Med Interne (Paris); 1998 Mar; 149(2):87-93. PubMed ID: 11490530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
    Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute leukemia and myelodysplasia in polycythemia vera. A clinical study with long-term follow-up.
    Najean Y; Deschamps A; Dresch C; Daniel MT; Rain JD; Arrago JP
    Cancer; 1988 Jan; 61(1):89-95. PubMed ID: 3334954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A contemporary approach to the diagnosis and management of polycythemia vera.
    Tefferi A
    Curr Hematol Rep; 2003 May; 2(3):237-41. PubMed ID: 12901345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycythemia vera: diagnosis and treatment 2002.
    Berlin NI
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):330-6. PubMed ID: 12113056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic transformation in polycythemia vera: analysis of risk factors.
    Nand S; Messmore H; Fisher SG; Bird ML; Schulz W; Fisher RI
    Am J Hematol; 1990 May; 34(1):32-6. PubMed ID: 2327402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycythemia vera: a retrospective and reprise.
    Berlin NI; Wasserman LR
    J Lab Clin Med; 1997 Oct; 130(4):365-73. PubMed ID: 9358074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course and transformation of polycythaemia vera in relation to therapy.
    Burger T; Schmelczer M; Molnár L; Pajor L; Koszorus S
    Acta Med Hung; 1988; 45(1):97-113. PubMed ID: 3412864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postpolycythemia myeloid metaplasia.
    Silverstein MN
    Arch Intern Med; 1974 Jul; 134(1):113-7. PubMed ID: 4833938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.